Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Murray

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Pediatric Blood & Cancer|May 27, 2023
Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International ConsortiumAna Glenda Santarosa Vieira, Vidya Puthenpura, Mark Krailo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
Solid tumors of childhood display specific serum microRNA profilesMatthew J Murray, Katie L Raby, Harpreet K Saini, et al.
Cancer Letters|July 28, 2021
The developmental origin of cancers defines basic principles of cisplatin resistanceMargaretha A Skowron, Christoph Oing, Felix Bremmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
"Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical TrialsMatthew J Murray, Hannah L Watson, Dawn Ward, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 15, 2023
Wilms Tumor With Raised Serum Alpha-Fetoprotein: Highlighting the Need for Novel Circulating BiomarkersRebecca Green, Adeeb Ahmed, Ben Fleming, et al.
Neuropathology and Applied Neurobiology|February 3, 2021
A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering managementKaran R Chadda, Katherine Holland, Daniel Scoffings, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
European Urology|June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic ReviewRicardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
Pediatric Blood & Cancer|April 19, 2025
Congenital Langerhans Cell Histiocytosis With Novel KCL1::RAF1 Gene Fusion Identified Through Routine Whole-Genome SequencingFiona E Wright, Gemma Barnard, Shivani Bailey, et al.
British Journal of Cancer|November 3, 2023
Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Pediatric Blood & Cancer|May 27, 2023
Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International ConsortiumAna Glenda Santarosa Vieira, Vidya Puthenpura, Mark Krailo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2014
Solid tumors of childhood display specific serum microRNA profilesMatthew J Murray, Katie L Raby, Harpreet K Saini, et al.
Cancer Letters|July 28, 2021
The developmental origin of cancers defines basic principles of cisplatin resistanceMargaretha A Skowron, Christoph Oing, Felix Bremmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
"Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical TrialsMatthew J Murray, Hannah L Watson, Dawn Ward, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 15, 2023
Wilms Tumor With Raised Serum Alpha-Fetoprotein: Highlighting the Need for Novel Circulating BiomarkersRebecca Green, Adeeb Ahmed, Ben Fleming, et al.
Neuropathology and Applied Neurobiology|February 3, 2021
A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering managementKaran R Chadda, Katherine Holland, Daniel Scoffings, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
European Urology|June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic ReviewRicardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
Pediatric Blood & Cancer|April 19, 2025
Congenital Langerhans Cell Histiocytosis With Novel KCL1::RAF1 Gene Fusion Identified Through Routine Whole-Genome SequencingFiona E Wright, Gemma Barnard, Shivani Bailey, et al.
British Journal of Cancer|November 3, 2023
Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruptionShivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, et al.
Pageof 14